ZNF137P: A Potential Drug Target and Biomarker (G7696)

ZNF137P: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transcription factors with abnormal gene expression and play an important role in a variety of physiological and pathological processes. The human ZNF137P gene is one of them and is also a member of the ZFP family. This gene plays an important role in a variety of cancers and is therefore considered a potential drug target and biomarker. This article will introduce the function, expression and possibility of ZNF137P gene as a drug target.

Function of ZNF137P gene

The ZNF137P gene is a protein-coding gene and belongs to the ZNF1 gene family. This gene is expressed in a variety of tissues, including neurons, liver cells, muscle cells and embryonic tissues. Under normal circumstances, the expression level of the ZNF137P gene is very low, but in various cancers, the expression level of the gene changes.

The protein function of the ZNF137P gene is an important gene that regulates tumor occurrence and development in various ways. It plays a role in promoting tumorigenesis in various cancers and is related to tumor invasion and metastasis. The expression level of ZNF137P gene is also related to the prognosis of various cancers, such as liver cancer, breast cancer and melanoma.

Expression of ZNF137P gene

The expression levels of the ZNF137P gene vary in different types of cells and tissues. The expression levels of ZNF137P gene also vary among different types of tumors. Generally speaking, the expression level of ZNF137P gene increases with tumor growth and progression, but in advanced tumors, the expression level decreases.

The expression level of the ZNF137P gene can be regulated in a variety of ways. For example, studies have found that the expression of the ZNF137P gene is regulated by the transcription factor SMAD. In addition, the expression level of the ZNF137P gene can also be affected by a variety of protein components, such as RNA-binding proteins (RBPs) and histone modifications.

Possibility of ZNF137P gene as a drug target

Because the ZNF137P gene plays an important role in a variety of cancers, it is considered a potential drug target. Currently, a variety of drugs have been developed to treat cancers related to the ZNF137P gene.

For example, researchers have developed a variety of drugs that inhibit ZNF137P gene expression, such as inhibitor of DNA binding (IDB) small molecule drugs and anti-tumor drugs. These drugs can significantly inhibit the growth and spread of tumor cells, thereby improving the survival rate of tumor patients.

In addition, researchers are also exploring the potential of the ZNF137P gene as a biomarker. For example, they are studying how to predict the survival of tumor patients by detecting the expression level of the ZNF137P gene and exploring the ZNF137P gene as a biomarker for tumor recurrence.

in conclusion

The ZNF137P gene is a gene that plays an important role in various cancers and can be used as a drug target and biomarker. Currently, a variety of drugs have been developed to treat cancers related to the ZNF137P gene, but more research still needs to be explored in depth. In the future, with the continuous advancement of technology, the ZNF137P gene will play a more important role in tumor research.

Protein Name: Zinc Finger Protein 137, Pseudogene

Functions: May be involved in transcriptional regulation

The "ZNF137P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF137P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283